Allmed Solutions Ltd

Tel Aviv Stock Exchange ALMD.TA

Allmed Solutions Ltd Free Cash Flow for the year ending December 31, 2023: USD 1.93 M

Allmed Solutions Ltd Free Cash Flow is USD 1.93 M for the year ending December 31, 2023, a 163.84% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Allmed Solutions Ltd Free Cash Flow for the year ending December 31, 2022 was USD -3.03 M, a -70.38% change year over year.
Allmed Solutions Ltd Free Cash Flow for the year ending December 31, 2021 was USD -1.78 M, a 36.15% change year over year.
Allmed Solutions Ltd Free Cash Flow for the year ending December 31, 2020 was USD -2.78 M, a 22.42% change year over year.
Allmed Solutions Ltd Free Cash Flow for the year ending December 31, 2019 was USD -3.59 M, a 17.28% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Tel Aviv Stock Exchange: ALMD.TA

Allmed Solutions Ltd

CEO	Prof. Oz Shapira
IPO Date	Dec. 24, 2007
Location	Israel
Headquarters	2 Ha'Eshel Street
Employees	19
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.

Key trends

Past 5 years